SLC5A2 and Hyperglycemia: Although further studies are necessary to fully elucidate the molecular mechanism underlying aortic inflammation induced by hyperglycemia, the anti-atherosclerotic effects of SGLT2 inhibitors might be mainly attributable to suppressed inflammation, which would eventually contribute to the prevention of CV events in diabetic patients.